Different effects of protamine on canine coronary microvessel and conductance arteries: Evidence of hyperpolarizing factor release

Surgery

Volumn 126, Issue 5, 1999, Pages 835-841

  Cable, David G ^a   Sorajja, Paul ^a   Oeltjen, Marilyn R ^a   Schaff, Hartzell V ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; INDOMETACIN; N(G) METHYLARGININE; NITRIC OXIDE; PROTAMINE SULFATE; TETRYLAMMONIUM CHLORIDE;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; HEART MUSCLE CAPILLARY; ISOLATED ARTERY; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0032740455     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(99)70023-1     Document Type: Article

References (32)

1. 1. Horrow JC. Protamine: a review of its toxicity. Anesth Analg 1985;64:348-61.
2. 2. Rogers K, Milne B, Salerno TA. The hemodynamic effects of intra-aortic versus intravenous administration of protamine for reversal of heparin in pigs. J Thorac Cardiovasc Surg 1983;85:851-5.
3. 3. Conahan TJ III, Andrews RW, MacVaugh H III. Cardiovascular effects of protamine sulfate in man. Anesth Analg 1981;60:33-6.
4. 4. Michaels IA, Barash PG. Hemodynamic changes during protamine administration. Anesth Analg 1983;62:831-5.
5. 5. Stoelting RK, Henry DP, Verburg KM, McCammon RL, King RD, Brown JW. Haemodynamic changes and circulating histamine concentrations following protamine administration to patients and dogs. Can Anaesth Soc J 1984;31:534-40.
6. 6. Frater RW, Oka Y, Hong Y, Tsubo T, Loubser PG, Masone R. Protamine-induced circulatory changes. J Thorac Cardiovasc Surg 1984;87:687-92.
7. 7. Casthely PA, Goodman K, Fyman PN, Abrams LM, Aaron D. Hemodynamic changes after the administration of protamine. Anesth Analg 1986;65:78-80.
8. 8. Withington DE, Man WK, Elliott MJ. Histamine release during paediatric cardiopulmonary bypass. Can J Anaesth 1993;40:334-9.
9. 9. Pearson PJ, Evora PR, Ayrancioglu K, Schaff HV. Protamine releases endothelium-derived relaxing factor from systemic arteries. A possible mechanism of hypotension during heparin neutralization. Circulation 1992;86:289-94.
10. 10. Akata T, Yoshitake J, Nakashima M, Itoh T. Effects of protamine on vascular smooth muscle of rabbit mesenteric artery. Anesthesiology 1991;75:833-46.
11. 11. Evora PR, Pearson PJ, Schaff HV. Protamine induces endothelium-dependent vasodilatation of the pulmonary artery. Ann Thorac Surg 1995;60:405-10.
12. 12. Kaiser L, Tithof PK, Williams JF. Depression of endothelium-dependent relaxation by filarial parasite products. Am J Physiol 1990;259:H648-52.
13. 13. Wang SY, Stamler A, Tofukuji M, Deuson TE, Sellke FW. Effects of blood and crystalloid cardioplegia on adrenergic and myogenic vascular mechanisms. Ann Thorac Surg 1997;63:41-9.
14. 14. Pearson PJ, Schaff HV, Vanhoutte PM. Long-term impairment of endothelium-dependent relaxations to aggregating platelets after reperfusion injury in canine coronary arteries. Circulation 1990;81:1921-7.
15. 15. Luscher TF, Diederich D, Siebenmann R, Lehmann K, Stulz P, von Segesser L, et al. Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med 1988;319:462-7.
16. 16. Mombouli JV, Vanhoutte PM. Kinins and endothelial control of vascular smooth muscle. Ann Rev Pharmacol Toxicol 1995;35:679-705.
17. 17. Taylor SG, Weston AH. Endothelium-derived hyperpolarizing factor: a new endogenous inhibitor from the vascular endothelium. Trends Pharmacol Sci 1988;9:272-4.
18. G-nitro-L-arginine in rats. Am J Physiol 1992;263:H1090-4.
19. 19. Clark SG, Fuchs LC. Role of nitric oxide and Ca++-dependent K+ channels in mediating heterogeneous microvascular responses to acetylcholine in diffferent vascular beds. J Pharmacol Exp Ther 1997;282:1473-9.
20. 20. Nakashima M, Mombouli JV, Taylor AA, Vanhoutte PM. Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. J Clin Invest 1993;92:2867-71.
21. 21. Kemp BK, Cocks TM. Evidence that mechanisms dependent and independent of nitric oxide mediate endothelium-dependent relaxation to bradykinin in human small resistance-like coronary arteries. Br J Pharmacol 1997;120:757-62.
22. 22. Garland CJ, Plane F, Kemp BK, Cocks TM. Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol Sci 1995;16:23-30.
23. 23. Mombouli JV, Vanhoutte PM. Endothelium-derived hyperpolarizing factor(s): updating the unknown. Trends Pharmacol Sci 1997;18:252-6.
24. 24. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 1996;78:415-23.
25. 25. Holzmann S, Kukovetz WR, Windischhofer W, Paschke E, Graier WF. Pharmacologic differentiation between endothelium-dependent relaxations sensitive and resistant to nitro-L-arginine in coronary arteries. J Cardiovasc Pharmacol 1994;23:747-56.
26. 26. Mombouli JV, Vanhoutte PM. Endothelium-derived hyperpolarizing factor(s) and the potentiation of kinins by converting enzyme inhibitors. Am J Hypertens 1995;8:19S-27S.
27. 27. Illiano S, Mombouli JV, Nagao T, Vanhoutte PM. Potentiation by trandolaprilat of the endothelium-dependent hyperpolarization induced by bradykinin. J Cardiovasc Pharmacol 1994;23(Suppl 4):S6-10.
28. 28. He GW, Yang CQ, Graier WF, Yang JA. Hyperkalemia alters EDHF-mediated hyperpolarization and relaxation in coronary arteries. Am J Physiol 1996;271:H760-7.
29. 29. He GW, Yang CQ. Hyperkalemia alters endothelium-dependent relaxation through non-nitric oxide and noncyclooxygenase pathway: a mechanism for coronary dysfunction due to cardioplegia. Ann Thorac Surg 1996;61:1394-9.
30. 30. He GW, Yang CQ, Yang JA. Depolarizing cardiac arrest and endothelium-derived hyperpolarizing factor-mediated hyperpolarization and relaxation in coronary arteries: the effect and mechanism. J Thorac Cardiovasc Surg 1997;113: 932-41.
31. 31. He GW. Hyperkalemia exposure impairs EDHF-mediated endothelial function in the human coronary artery. Ann Thorac Surg 1997;63:84-7.
32. 32. Sorajja P, Cable DG, Schaff HV. Hypothermic storage with University of Wisconsin solution preserves endothelial and vascular smooth-muscle function. Circulation 1997;96 Suppl 2:297-302.